Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Surg Oncol. 2017 Aug 2;116(8):969–982. doi: 10.1002/jso.24774

Table 4.

Details of evaluations of tool internal and external validity (n=53 tools)

Performance Measure Internal Validation (n= 45 tools) External Validation (n= 79 validations)

Internal Validation Method*
Apparent 27 (60) --
Cross-Validation 2 (4) --
Split Sample 6 (14) --
Bootstrapping 10 (22) --

External Validation Method
Independent -- 61 (77)
Geographic -- 13 (16)
Temporal -- 3 (4)
Other** 2 (3)

Overall Model Performance
R-squared 2 (4) 2 (3)

Calibration
Graph (Plot/intercept/slope) 11 (25) 4 (5)
Hosmer/Lemeshow statistic 3 (7) 0 (0)
Sub-group calibration*** 2 (5) 5 (6)

Discrimination
C-statistic**** 21 (48) 33 (42)

Survival Analysis Only with Significance Test 22 (50) 40 (51)
*

One tool applied both split sample and bootstrap methods;

**

An RCT(s) was used to develop the prognostic tool, and an additional RCT was used for validation;

***

Tables comparing predicted and observed values for groups of patients were provided;

****

Concordance index based on the ROC for binary data, Harrell’s C statistic for models using time to event data